• AIMECS 2019
• ICCST 2018
• EUROQSAR-2018 Symposium
• CMTPI 2009
• WCADD-2 Workshop
• AIMECS 07 (6th AFMC Symposium)
• WCADD-1 Workshop
• EUROQSAR-2004 Simpósium

AIMECS 07 (6th AFMC Symposium)

It's been a great honour for us to be with you in the AIMECS 07, the 6th International Medicinal Chemistry Symposium organized by the Asian Federation of Medicinal Chemistry (AFMC), held in Istanbul-Turkey from July 08-11, 2007.

The 6th AFMC International Medicinal Chemistry Symposium has gathered the medicinal chemists from all over the world by the contribution of the European Federation of Medicinal Chemistry (EFMC) and the American Chemical Society Division of Medicinal Chemistry (ACSMC) as the participating organizations within this World Summit in Istanbul, the city that bridges the two great continents Asia and Europe.

Total number of participation to the AIMECS 07 was 441. Participants were from 42 different countries all over the world. These countries were China, Hong Kong, Indenosia, India, Iran, Iraq, Israel, Japan, Korea, Kyrgyztan, Singapore, Taiwan, Thailand from Asia; Belgium, Crotia, Czech Republic, England, France, Germany, Greece, Holland, Hungary, Italy, Latvia, Poland, Portugal, Romania, Russia, Spain, Sweden, Switzerland, Ukraine from the continent Europe; Algeria, Cameroon, Egypt, Ghana, Nigeria, South Africa from Africa; Canada, USA, Brazil from America; Australia from Ocenia and Turkey, a bridge between two continents, from both Europe and Asia as the host country.

Distribution of the Participants: 

220 from ACADEMIA, 50 %
95 from INDUSTRY, 21.5 %
126 as STUDENTS, 28.5 % 

...Click on the AIMECS 07 Group Picture to enlarge it...

Opening Lecture: “Strategy-Life Cycle Management of Drugs” by Toshi-Hiko KOBAYASHI, AFMC Past President, PhRMA (USA), Japan

Syposium Web Site: www.aimecs07.org

Organizing Committee

Scientific Advisory Board

AIMECS 07 Organized by Asian Federation for Medicinal Chemistry

 The Pharmaceutical Society of Japan (PSI)
 The Chemical Society of Japan (CSI)
 Japan Society for Bioscience, Biotechnology and Agrochemistry (JSBBA)
 The Society of Synthetic Organic Chemistry, Japan (SSOCJ)
 The Pharmaceutical Society of Korea (PSK)
 The Korean Chemical Society (KCS)
 Chinese Pharmaceutical Association (CPA)
 China Pharmaceutical Industry Association (CPIA)
 The Royal Australian Chemical Institute (RACI)
 Chemical Society Located in Taipei (CSLT)
 The Computer Aided Drug Design & Development Society in Turkey (CADD&D)

Managed by

 The Computer Aided Drug Design & Development Society in Turkey (CADD&D)

Participating Organizations

 European Federation for Medicinal Chemistry (EFMC)
 American Chemical Society, Division of Medicinal Chemistry (ACSMC)

Sponsored by

 The International Union of Pure and Applied Chemistry (IUPAC)
 The Scientific and Technological Research Council of Turkey (TUBITAK)

Plenary Lecturers

 Masakatsu SHIBASAKI, The University of Tokyo, Japan
 Colin WARD, CSIRO Molecular&Health Technologies, Australia
 Johann GASTEIGER, Computer-Chemie-Centrum, Germany

Invited Lecturers

 Raymond J. ANDERSEN, University of British Columbia Vancouver, Canada
 Patrick CHENE, Novartis, Switzerland
 Alex TROPSHA, University of North Carolina at Chapel Hill, USA
 Hajime OHIGASHI, Kyoto University, Japan
 Hisayoshi MORIAOKA, Ministry of Health, Labour and Welfare, Japan
 Lak Shin JEONG, Ewha Womans University, Korea
 Kazuei IGARASHI, Chiba University, Japan
 Victor KARTSEV, InterBioScreen, Russia
 Peter HENDERSON, University of Leeds, UK
 Nobutaka FUJII, Kyoto University, Japan
 Frank E. BLANEY, Computational&Structural Chemistry, UK
 Soon Kil AHN, Chong Kun Dang Research Institute, Korea

Oral Presenters

 Jose A. SALAS, Oncologia del Principado de Asturias, Spain
 Jurgen ROHR, University of Kentucky, USA
 Ming-Qiang ZHANG, Biotica Technology Ltd., UK
 Frank E. KOEHN, Wyeth Research, New York, USA
 Mino CAIRA, University of Cape Town, South Africa
 Xavier BARRIL, Barcelona University, Spain
 Turkan HALILOGLU, Bogazici University, Turkey
 Alessio CIULLI, University of Cambridge, UK
 Ichio SHIMADA, University of Tokyo, Japan
 Massimiliano BONOMI, Computational Science, Switzerland
 Maurizio BOTTA, Dipartimento Farmaco Chimico Tecnologico, Italy
 Gregory J. TAWA, Wyeth Research, USA
 Ilkay YILDIZ, Ankara University, Turkey
 Pietro COZZINI, University of Parma, Italy
 Bo Cheng WANG, Tamkang University, Taiwan
 Vladimir A. PALYULIN, Moscow State University, Russia
 Hirokazu KAWAGISHI, Shizuoka University, Japan
 Hiroshi TERADA, Tokyo University of Science, Japan
 Jonathan B. BAELL, The Walter and Eliza Hall Institute of Medical Research, Australia
 Yutaka EBIZUKA, University of Tokyo, Japan
 Jian-Yong WU, Hong Kong Polytechnic University, China
 Mark PAXTON, PhRMA, USA
 Michael J. CAINE, Australia
 Hulya CAYLI, Paragon Consultancy Incorporated, Turkey
 Sanghee KIM, Seoul National University, Korea
 Jae-Sang RYU, Ewha Womans University, Korea
 Moohi YOO, Dong-A Pharmaceutical Co., Korea
 Mao-Sheng CHENG, Shenyang Pharmaceutical University, China
 Yong-Chul KIM, Gwangju Institute of Science and Technology, Korea
 Tetsuo NAGANO, University of Tokyo, Japan
 Naoki UMEZAWA, Nagoya City University, Japan
 Norio MATSUKI, University of Tokyo, Japan
 David ARAGONES, Prous Institute for Biomedical Research, Spain
 Tomofumi SANTA,  University of Tokyo, Japan
 Jung-Mi HAH, Korea Institute of Science and Technology, Korea
 David Winkler, CSIRO Molecular&Health Technologies, Australia
 Jasbir Singh, deCODE Chemistry&Biostructures, Iceland
 Nino RUSSO, Universita della Calabria, Italy
 Yousef AL-ABED, Yale University, USA
 Vladimir POTEMKIN, Chelyabinsk State University, Russia
 Hermann LAGE, Institute of Pathology, Germany
 Renate GRIFFITH, University of Newcastle, Australia
 Tanil KOCAGOZ, Yeditepe University, Turkey
 Po-Huang LIANG, Academia Sinica, Taiwan
 NAgy MORSY, Osaka University, Japan
 Biing-Jiun UANG, National Tsing Hua University, Taiwan
 Tetsuro KIKUCHI, Otsuka Pharmaceutical Co. Ltd., Japan
 Yuusaku YOKOYAMA, Toho University, Japan
 Kunisuke IZAWA, Ajinomoto Co. Inc., Japan
 Dae-Kee KIM, Ewha Womans University, Korea
 Henry J. LEE, FLorida A&M University, USA
 Jih Ru HWU, National Tsing Hua University, Taiwan
 Thomas MAVROMOUSTAKOS, The National Hellenic Research Foundation, Germany
 Noritaka KURODA, Takeda Pharmaceutical Company Ltd., Japan
 Serdar KUYUCAK, University of Sydney, Australia
 Tomoyuki SAITO, University of Toyama, Japan
 Hsing-Pang HSIEH, National Health Research Institutes, Taiwan
 Seonggu RO, CrystalGenomics Inc., Korea
 Jang-Yang CHANG, National Health Research Institutes, Taiwan
 Aleem GANGJEE, Duquesne University, USA
 Alessandra MAGISTRATO, CNR-INFM, Italy
 Vasiliki VALLA, Aristotle University of Thessaloniki, Greece

Topics of the AIMECS 07 Symposium

Chemistry for pharmaceuticals
 New synthetic methods
 Process chemistry
 Biomimetics
 Chemical genomics

New drug targets
 Endogenous substances
 Receptors, enzymes, channels
 Glycoproteins
 Genomic pharmacology

ADME/Tox.
 Drug metabolism and toxicology
 Drug delivery
 Medicinal bioengineering
 Biomaterials

New methods for drug discovery
 Analytical & physico-pharmaceutical chemistry
 High-throughput medicinal & combinatorial advances
 Lead identification & optimization
 Glycotechnology

Predictive in silico methods
 Bioinformatics
 Structural biology for drug development
 Complex systems approaches
 Cheminformatics and QSAR
 Computational chemistry

Protein-Protein Interactions (EFMC Session)

Reversal of multi-drug resistance
 New Antibiotics
 New Antifungal Agents
 New Antiviral Agents

Natural products in drug discovery

Recent approaches in anticancer therapy

Biomarkers in HPS through clinical development

Intellectual Property (IP) and Regulatory affairs
 Patenting
 Clinical trials issues
 Registration issues
 Spinoffs and new businesses

The role and significance of Preclinical studies in drug development

Recent Innovations in the Development of Anti-tumor Natural Products (ACSMC Session)